BioSpace News Archive

Biotech Beach

Sorrento Mexico and the National Institute of Genomic Medicine (INMEGEN) of Mexico Government Execute Memorandum of Understanding (MOU) for Rapid Clinical Development of COVID-19 Diagnostics

Sorrento Therapeutics, Inc. today announced that its subsidiary company, Sorrento Therapeutics Mexico has entered into an MOU agreement with the National Institute of Genomic Medicine INMEGEN to cooperate in the development, testing and support of multiple COVID-19 related products Sorrento plans to commercialize in Mexico.

August 3, 2021
·
6 min read
Business

Gracell Biotechnologies to Report Second Quarter Financial Results on Tuesday, August 17, 2021

Gracell Biotechnologies Inc. today announced that it will release financial results for the second quarter ended June 30, 2021, prior to the open of the U.S. financial markets on Tuesday, August 17.

August 3, 2021
·
1 min read
FDA

Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart

Abbott today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company’s new Ultreon Software.

August 3, 2021
·
3 min read
Business

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®

Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu will have exclusive distribution rights for the following prescription medicines in Korea: Lamisil® for the treatment of athlete’s foot; Lescol® XL for the treatment of dyslipidemia; and the Tegretol® for the treatment of epilepsy.

August 3, 2021
·
2 min read
Pharm Country

Catalent Achieves 97% Renewable Electricity Sourcing and Commits to Science-Based Target Initiative to Reduce Carbon Footprint

Catalent, Inc. announced that, effective July 1, 2021, 97% of its electricity usage across its global network is being procured from renewable energy sources such as wind, solar, hydroelectric, and biomass.

August 3, 2021
·
6 min read
Business

Meissa Appoints Robert Walker, M.D., Chief Medical Officer

Meissa Vaccines announced today the appointment of Robert Walker, M.D., as Chief Medical Officer.

August 3, 2021
·
4 min read
Business

Personal Genome Diagnostics Appoints Jamie Platt, Ph.D., as Chief Operations Officer

Personal Genome Diagnostics Inc. today announced the appointment of Jamie Platt, Ph.D., as Chief Operations Officer.

August 3, 2021
·
3 min read
FDA

FDA Approves New BERINERT® (C1 Esterase Inhibitor, Human (Intravenous)) Administration Kit for Increased Patient Convenience

CSL Behring received U.S. Food and Drug Administration (FDA) approval for its supplemental request (submitted Aug. 30, 2020 ) for co-packaging of a convenience administration kit along with its product BERINERT.

August 3, 2021
·
5 min read
Deals

Veranex Announces Acquisition of Experien Group

Veranex today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies.

August 3, 2021
·
2 min read
Drug Development

U.S. Phase 2 Study Published in OSLI Retina Highlights the Safety and Efficacy of Risuteganib in Patients with Dry Age-Related Macular Degeneration

Allegro Ophthalmics today announced that the results of the company’s U.S. Phase 2a risuteganib non-exudative age-related macular degeneration (dry AMD) study are published in Ophthalmic Surgery, Lasers, and Imaging (OSLI) Retina.

August 3, 2021
·
3 min read